http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2257921-C2
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-02 |
filingDate | 2002-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fb8683e3d5e21df26034fbed1e18c9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d90c0ffc4adb6dac4885dfe8059e6fe7 |
publicationDate | 2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2257921-C2 |
titleOfInvention | Method for treating uterine myoma in combination with mastopathy |
abstract | FIELD: medicine, gynecology. n SUBSTANCE: one should affect biologically active points as VC-17 and RP-6 with electromagnetic waves of mm-range in interval of 60.0-61.8 hHz and density of power flow of 1.0-1.5 mW/sq. cm. Every female patient should be affected with individually matched frequency with the help of "Stella 2 " apparatus with an in-built electroconductivity indication block of acupuncture points for 14-16 min/each beginning since the 5 th -7 th d of menstrual cycle daily from 9 a.m. till 12 a.m. The rapeutic course consists of 10-12 procedures. The method enables to demonstrate direct depressive action towards any tumor growth. n EFFECT: higher inspecific body resistance. n 2 ex,1 tbl |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2508086-C1 |
priorityDate | 2002-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.